Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10324 |
| Vaccine Name | INO-4800 |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | RNA based vaccine |
| Vaccine Status | Phase 3 |
| Manufacturer | Inovio Pharmaceuticals |
| Year of Manufacturing | 2021 |
| Manufacturing Country | USA |
| Age | 18 years and above |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intradermal |
| Adjuvant | NA |
| Target Strain | Spike protein of SARS-CoV-2 virus |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 32328406 |
| Clinical Trial ID | NA |
| Reference Link | https://pubmed.ncbi.nlm.nih.gov/32328406/ |
| Additional Links | https://ir.inovio.com/news-releases/news-releases-details/2021/INOVIO-Further-Expands-INNOVATE-Phase-3-Trial-for-COVID-19-DNA-Vaccine-Candidate-INO-4800-With-Regulatory-Authorization-from-India/default.aspx |